Growth Metrics

Castle Biosciences (CSTL) Equity Income (2024 - 2025)

Historic Equity Income for Castle Biosciences (CSTL) over the last 2 years, with Q3 2025 value amounting to $3.6 million.

  • Castle Biosciences' Equity Income changed N/A to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year change of. This contributed to the annual value of $600000.0 for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Castle Biosciences' Equity Income stood at $3.6 million.
  • Over the past 5 years, Castle Biosciences' Equity Income peaked at $3.6 million during Q3 2025, and registered a low of -$1.4 million during Q1 2025.